Family of opioid-addicted baby sues pharmaceutical companies

2018-03-06 07:27
(iStock)

(iStock)

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Illinois — An Illinois family of a baby born addicted to opioids is suing 20 pharmaceutical companies alleging they're responsible for the mother's addiction to opioids and heroin.

The lawsuit states that a baby, identified by his initials T.W.B., was born in March 2017 and diagnosed with Neonatal Abstinence Syndrome, which can cause breathing and feeding problems. The lawsuit says baby T.W.B. spent his first days in "excruciating pain" as he weaned from an opioid addiction inherited from his mother, the Belleville News-Democrat reported.
 
The baby's grandparents, Deric and Ceonda Rees, filed the lawsuit in the US District Court of Southern Illinois Wednesday. Ceonda Rees declined the newspaper's request for comment.

"Baby T.W.B. will require years of treatment and counselling to deal with the effects of prenatal exposure," the lawsuit states. "Baby T.W.B. and his mother are victims of the opioid crisis that has ravaged Illinois, causing immense suffering to those born addicted to opioids and great expense to those forced to deal with the aftermath."

Babies can also suffer birth defects if a mother takes opioids while pregnant, according to Stanford Children's Health. The National Institute on Drug Abuse has reported that the number of babies born with Neonatal Abstinence Syndrome has increased fivefold since 2000.

According to the lawsuit, the baby's mother became addicted to opioids after she was prescribed them for a broken ankle and hand as a teenager. Her prescription opiates addiction later became a gateway to a heroin addiction. The lawsuit alleges that the mother has consumed drugs produced and distributed by the 20 companies, such as Dilaudid, Percocet, Oxycodone and Hydrocodone.

The lawsuit also alleges that the pharmaceutical companies are responsible for "false, negligent and unfair marketing/unlawful diversion of prescription opioids".

The family has requested equitable relief and medical monitoring to help identify developmental issues and to pay for treatment.

Janssen Pharmaceuticals, Inc., Purdue Pharma, Allergan and Teva Pharmaceuticals released statements in response to the lawsuit. Three companies didn't respond for comment and two declined.


Read more on:    us  |  narcotics

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.
NEXT ON NEWS24X

Inside News24

 
/News
Traffic Alerts
Traffic
There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.